| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/10/2011 | WO2011028618A1 Composition and method for reducing blood glucose levels |
| 03/10/2011 | WO2011028344A2 Interleukin-1 receptor antagonist compositions and methods of making and using same |
| 03/10/2011 | WO2011027888A1 Diamide-phenyl derivative and pharmaceutically acceptable salt thereof |
| 03/10/2011 | WO2011027849A1 Heterocyclic compound |
| 03/10/2011 | WO2011027839A1 Cholesterol-efflux peptide |
| 03/10/2011 | WO2011026781A1 Novel multifunctional peptidase inhibitors, especially for medical use |
| 03/10/2011 | WO2011026259A1 Pharmaceutical compositon for anti-thrombotic diseases, its preparation method and use |
| 03/10/2011 | WO2010134756A3 Composition comprising green tea extract |
| 03/10/2011 | WO2010132389A3 Methods for treating cancers and diseases associated with 4-1bb (cd137) expression |
| 03/10/2011 | WO2010037127A8 Chromenone analogs as sirtuin modulators |
| 03/10/2011 | US20110061114 Novel pro258 gene disruptions, and methods relating thereto |
| 03/10/2011 | US20110060060 Pterostilbene as a New Agonist for the Peroxisome Proliferator-Activated Receptor Alpha Isoform |
| 03/10/2011 | US20110060051 Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and beta-cell dysfunction |
| 03/10/2011 | US20110060034 Cell transdifferentiation into brown adipocytes |
| 03/10/2011 | US20110060030 Modulation of apolipoprotein c-iii expression |
| 03/10/2011 | US20110060024 Modulators of ATP-Binding Cassette Transporters |
| 03/10/2011 | US20110060022 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]Benzoic Acid - 465 |
| 03/10/2011 | US20110060019 Heteroaryl-ureas and their use as glucokinase activators |
| 03/10/2011 | US20110060017 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 03/10/2011 | US20110060014 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 03/10/2011 | US20110060007 Novel NIP Thiazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydroge-Nase-1 |
| 03/10/2011 | US20110060006 Functionally Selective Alpha2C Adrenoreceptor Agonists |
| 03/10/2011 | US20110060003 Lonidamine analogues for fertility management |
| 03/10/2011 | US20110060001 Thienopyridone derivatives as amp- activated protein kinase (ampk) activators |
| 03/10/2011 | US20110059999 Hydroxymethylcyclohexylamines |
| 03/10/2011 | US20110059997 SUBSTITUTED CYCLOALCANO[e AND d] PYRAZOLO [1,5-a]PYRIMIDINES/ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS AND METHODS FOR PRODUCTION AND THE USE THEREOF |
| 03/10/2011 | US20110059995 Substituted xanthine derivatives |
| 03/10/2011 | US20110059986 Intermittent dosing regimen for overweight and obese subjects |
| 03/10/2011 | US20110059976 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 03/10/2011 | US20110059969 Piperazines as anti-obesity agents |
| 03/10/2011 | US20110059966 Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
| 03/10/2011 | US20110059965 Bicyclic derivatives as modulators of ion channels |
| 03/10/2011 | US20110059964 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 03/10/2011 | US20110059963 Compounds and methods for kinase modulation, and indications therefor |
| 03/10/2011 | US20110059959 Novel multicyclic compounds and the use thereof |
| 03/10/2011 | US20110059957 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 03/10/2011 | US20110059952 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 03/10/2011 | US20110059945 S1P Receptor Modulating Compounds and Use Thereof |
| 03/10/2011 | US20110059942 Azetidinyl G-Protein Coupled Receptor Agonists |
| 03/10/2011 | US20110059941 2-phenyl substituted imidazol [4,5b] pyridine/pyrazine and purine derivatives as glucokinase modulators |
| 03/10/2011 | US20110059935 Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS |
| 03/10/2011 | US20110059932 Liver x receptor agonists |
| 03/10/2011 | US20110059930 Composition for the Regulation of the Human Immune System and the Prevention and Treatment of Diseases Thereof |
| 03/10/2011 | US20110059929 SUBSTITUTED BICYCLIC PIPERIDINYL-AND PIPERAZINYL- SULFONAMIDES USEFUL TO INHIBIT 11beta-HYDROXYSTEROID DEHYDROGENASE TYPE-1 |
| 03/10/2011 | US20110059927 Calcium Formate For Use As A Dietary Supplement |
| 03/10/2011 | US20110059923 Novel phosphate or a pharmaceutically acceptable salt thereof, a production method therefor and a pharmaceutical composition for preventing and treating central nervous system disorders containing the same as an active component |
| 03/10/2011 | US20110059916 Methods and Compositions for Inducing Torpor in a Subject |
| 03/10/2011 | US20110059912 Combination therapy comprising sglt inhibitors and dpp4 inhibitors |
| 03/10/2011 | US20110059910 Novel aromatic fluoroglycoside derivatives, pharmaceuticals comprising said compounds and the use thereof |
| 03/10/2011 | US20110059889 PEPTIDES THAT BLOCK THE BINDING OF IgG TO FcRn |
| 03/10/2011 | US20110059888 Metastin derivatives and use thereof |
| 03/10/2011 | US20110059887 Meal-time insulin analogues of enhanced stability |
| 03/10/2011 | US20110059170 Methods for administering weight loss medications |
| 03/10/2011 | US20110059165 Seamless alginate capsules |
| 03/10/2011 | US20110059159 Nanoscale bound bilayers, methods of use and production |
| 03/10/2011 | US20110059158 Charged phospholipid compositions and methods for their use |
| 03/10/2011 | US20110059118 Inhibitors of jak |
| 03/10/2011 | US20110059117 Liquid Compositions Capable of Foaming and Including Active Agents, and Methods for Making or Developing Same |
| 03/10/2011 | US20110059084 Agent for treating disease |
| 03/10/2011 | US20110059083 Agent for treating disease |
| 03/10/2011 | US20110059080 Use of an anti-il6 antibody to decrease hepcidin in cancer patients |
| 03/10/2011 | US20110059053 Method of treating biocells |
| 03/10/2011 | US20110059051 Molecular Control of Brown Fat Differentiation and Engergy Expenditure |
| 03/10/2011 | CA2846746A1 Pcsk9 vaccine |
| 03/10/2011 | CA2772975A1 Novel multifunctional peptidase inhibitors, especially for medical use |
| 03/10/2011 | CA2772718A1 Compounds as tyrosine kinase modulators |
| 03/10/2011 | CA2772714A1 Heterocyclic compounds for the inhibition of pask |
| 03/10/2011 | CA2772618A1 Fatty acid niacin conjugates and their uses |
| 03/10/2011 | CA2771352A1 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 03/09/2011 | EP2292771A2 Sense mRNA therapy |
| 03/09/2011 | EP2292758A2 Uses of mammalian cytokine; related reagents |
| 03/09/2011 | EP2292620A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prohylaxis and treatment of disorders related thereto |
| 03/09/2011 | EP2292614A1 Substituted pyrimidines as aurora kinase inhibitors |
| 03/09/2011 | EP2292611A1 Novel thiophenediamine derivative having urea structure |
| 03/09/2011 | EP2292600A1 Crystaline forms VI and VII of atorvastatin calcium |
| 03/09/2011 | EP2292596A2 CETP activity inhibitor |
| 03/09/2011 | EP2292595A1 Potassium channel modulators |
| 03/09/2011 | EP2292589A1 Novel multifunctional peptidase inhibitors, especially for medical use |
| 03/09/2011 | EP2292576A2 Retinoids useful in the treatment of cancer and for reducing serum triglycerides |
| 03/09/2011 | EP2292301A2 Anti-interferon-alpha antibodies |
| 03/09/2011 | EP2292275A2 Protecting therapeutic compositions from host-mediated inactivation |
| 03/09/2011 | EP2292273A2 Remodeling and glycoconjugation of peptides |
| 03/09/2011 | EP2292272A2 Polypeptide protracting tags comprising a tetrazole moiety |
| 03/09/2011 | EP2292271A2 Remodelling and glycoconjugation of an antibody |
| 03/09/2011 | EP2292268A1 Pharmaceutical composition for use in treatment of diabetes |
| 03/09/2011 | EP2292256A2 High mannose proteins and methods of making high mannose proteins |
| 03/09/2011 | EP2292232A1 Beta-amino tetrahydroimidazo(1,2-A)pyrazines and tetrahydrotriazolo(4,3-A)pyrazines for use in the treatment of diabetes type II |
| 03/09/2011 | EP2292228A1 Pyrazole derivatives as 11-beta-HSD1 inhibitors |
| 03/09/2011 | EP2292224A1 Precursor compounds of sweet receptor antagonists for preventing or treating diabetes |
| 03/09/2011 | EP2292223A1 Polyunsaturated fatty acid supplements |
| 03/09/2011 | EP2292220A2 Composition and methods for increasing insulin sensitivity |
| 03/09/2011 | EP2292211A2 Mucoadhesive pharmaceutical formulations |
| 03/09/2011 | EP2292091A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 03/09/2011 | EP2291400A1 Method of diagnosis of infection by mycobacteria and reagents therefor |
| 03/09/2011 | EP2291352A2 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway |
| 03/09/2011 | EP2291351A1 Alpha-mercapto-amides |
| 03/09/2011 | EP2291182A1 Salicylate conjugates useful for treating metabolic disorders |
| 03/09/2011 | EP2079747B1 Heterocyclic compounds useful as anabolic agents for livestock animals |
| 03/09/2011 | EP2040566B1 Milk fever |
| 03/09/2011 | EP1836206B1 Azolopyrimidine-based inhibitors of dipeptidyl peptidase iv and methods |